Midased
Midased is a brand of Midazolam, a fast-acting benzodiazepine. It acts on the central nervous system to produce sedative, anxiolytic, muscle-relaxing, and anticonvulsant effects by enhancing the activity of the inhibitory neurotransmitter GABA.
Dosage by Body Weight
Dosage is highly individualized and must be determined by a healthcare professional. It depends heavily on the patient's age, weight, physical status, and the specific clinical indication. Constant monitoring of respiratory and cardiac function is required during administration.
- Body Weight
- Below 5 kg
- Dose
- 0.1 mg to 0.2 mg/kg
- Frequency
- Single dose as prescribed
- Tracking Notes
- Extremely high risk of respiratory depression; must be administered in a clinical setting with emergency resuscitation equipment available.
- Body Weight
- 5-7 kg
- Dose
- 0.5 mg to 1.4 mg
- Frequency
- Single dose as prescribed
- Tracking Notes
- Dosing depends on route (IV, IM, nasal, or oral). For emergency seizure control only.
- Body Weight
- 8-10 kg
- Dose
- 0.8 mg to 2.0 mg
- Frequency
- Single dose as prescribed
- Tracking Notes
- Commonly titrated slowly to achieve the desired level of conscious sedation.
- Body Weight
- 11-15 kg
- Dose
- 1.1 mg to 3.0 mg
- Frequency
- Single dose as prescribed
- Tracking Notes
- Monitor oxygen saturation and respiratory rate continuously.
- Body Weight
- 16-20 kg
- Dose
- 1.6 mg to 4.0 mg
- Frequency
- Single dose as prescribed
- Tracking Notes
- Lower doses may be required if co-administered with other central nervous system depressants.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | 0.1 mg to 0.2 mg/kg | Single dose as prescribed | Extremely high risk of respiratory depression; must be administered in a clinical setting with emergency resuscitation equipment available. |
| 5-7 kg | 0.5 mg to 1.4 mg | Single dose as prescribed | Dosing depends on route (IV, IM, nasal, or oral). For emergency seizure control only. |
| 8-10 kg | 0.8 mg to 2.0 mg | Single dose as prescribed | Commonly titrated slowly to achieve the desired level of conscious sedation. |
| 11-15 kg | 1.1 mg to 3.0 mg | Single dose as prescribed | Monitor oxygen saturation and respiratory rate continuously. |
| 16-20 kg | 1.6 mg to 4.0 mg | Single dose as prescribed | Lower doses may be required if co-administered with other central nervous system depressants. |
Formulation
Purpose
Used for pre-operative sedation, induction and maintenance of anesthesia, and the control of acute prolonged seizures (status epilepticus).
Generic Name
MidazolamScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.